55results about How to "Disease relief" patented technology

A system for implanting a surgical device to control the circumference of internal anatomic passages corrects physiologic dysfunctions resulting from a structural lumen which is either too large or too small. Implants are disclosed which employ various means for adjusting and maintaining the size of an orifice to which they are attached. Systems permit the implants to be implanted using minimally invasive procedures and permit final adjustments to the circumference of the implants after the resumption of normal flow of anatomic fluids in situ. Methods are disclosed for using the implants to treat heart valve abnormalities, gastroesophageal abnormalities, anal incontinence, and the like.

Methods for treating peptic ulcers and methods for treating gastroesophageal reflux disease by oral administration of a botulinum toxin.

The present invention relates to improvements in the field of drug delivery. More particularly, the invention relates to a non-invasive and flexible method and carrier for transporting a compound or drug across the blood-brain barrier of an individual. In particular the present invention relates to a carrier for transporting an agent attached thereto across a blood-brain barrier, wherein the carrier is able to cross the blood-brain barrier after attachment to the agent and thereby transport the agent across the blood-brain barrier. The present invention relates to improvements in the field of drug delivery. More particularly, the invention relates to a non-invasive and flexible method and carrier for transporting a compound or drug across the blood-brain barrier of an individual. In particular the present invention relates to a carrier for transporting an agent attached thereto across a blood-brain barrier, wherein the carrier is able to cross the blood-brain barrier after attachment to the agent and thereby transport the agent across the blood-brain barrier.

The present invention provides dietary formulations comprising polyunsaturated fatty acids and vitamin E. The present invention further provides methods of treating various conditions, generally involving administering to an individual in need thereof an effective amount of a subject dietary formulation.

The present invention provides methods of treating a fibrotic disorder. The methods generally involve administering an effective amount of IFN-γ and an effective amount of pirfenidone or a pirfenidone analog.

An article of furniture for placing an electronic device is provided. The furniture provides a support board for placing an electronic device at a position of palms where a user's hands naturally drop down, such that the user operates the electronic device with the hand at the position where the hand naturally drop down. Thus, the user's hand muscles are relaxed. Although the user controls the electronic device with the hands for a long time, the hands do not hurt.

The invention relates to antisense oligonucleotides that are capable of bringing about specific editing of a target nucleotide (adenosine) in a target RNA sequence in a eukaryotic cell, wherein said oligonucleotide does not, in itself, form an intramolecular hairpin or stem-loop structure, and wherein said oligonucleotide comprises a non-complementary nucleotide in a position opposite to the nucleotide to be edited in the target RNA sequence.

The invention relates to a high efficient and multifunctional backbone treatment couch, comprising a couch body; the couch is characterized in that the couch surface of the couch body is a couch plate for patients to lie down in two directions; one end of the couch plate is provided with two slots corresponding to cervical vertebra and lumbar of a patient respectively; the two slots are respectively provided with a corrective, the lower end of the correctives are fixedly connected with a lifting mechanism which enables the correctives to carry out upward and downward displacement; the other end of the couch plate is provided with a fumigating hole respectively corresponding to cervical vertebra and lumbar of the patient; a fumigating barrel containing fumigating liquid medicine which can be respectively connected and used with the fumigating holes in a movable way is also provided; a leg fixing band is arranged at the fumigating hole end of the couch plate. The treatment couch of the invention has the beneficial effects that the treatment effects are improved, the intervertebral discs are restored; moreover, the couch bed is designed in a scientific and safe way; in particular, music remedy is added to backbone correcting treatment, thus serving to improve mentality of the patient; furthermore, the device can be directly applied to families where the patient can be treated by following the advice of the doctor, thus saving time and trouble, offering a convenient and cozy environment and accelerating recovery.

The present invention provides methods and compositions for increasing the growth rates, alleviating the symptoms, or improving the metabolism of human patients having insulin-like growth factor-1 deficiency (IGFD). The invention relates to methods comprising administering insulin-like growth factor-I to a patient having a height which, at the time of treatment or prior to initial treatment with IGF-1, is at least about 2 standard deviations below normal for a subject of the same age and gender, a blood level of insulin-like growth factor-I that, and at the time of treatment or prior to initial treatment with IGF-1, is below normal mean levels, usually at least about 1 standard deviations below normal mean levels, for age and gender.

Methods and compositions for determining whether a subject at least has a neoplastic disease are provided. In practicing the subject methods, a sample from a subject is assayed for a soluble filamin analyte, such as a filamin A analyte, to determine whether the subject at least has the neoplastic disease. Also provided are kits, systems, and devices for practicing the subject methods.

The present invention provides methods for treating individuals having an HCV infection, which individuals have failed to respond to therapy with an INF-α other than consensus interferon (CIFN), or who, following cessation of therapy with an INF-α other than CIFN, have suffered relapse. The methods generally involve a dosage regimen involving administering a dose of CIFN and a dose of ribavirin for a period of time, where the dosage regimen is effective to achieve a sustained viral response in the individual.

The invention relates to a new neurotensin analogue, or a salt thereof, useful for targeting to neurotensin receptor-positive tumors, like ductal pancreatic adenocarcinoma, exocrine pancreatic cancer, invasive ductal breast cancers, colon adeno-carcinoma, small cell lung carcinoma, Ewing sarcoma, meningioma, medulloblastoma and astrocytoma.

The present invention is directed to methods of treating and/or ameliorating portal hypertension by administration of a therapeutically effective amount of ifetroban or a pharmaceutically acceptable salt thereof.

The invention discloses antiviral bacteriostatic respiratory tract compound essential oil and a preparation method thereof, relates to the technical field of essential oil, and aims to solve problemsthat existing essential oil mainly has the effects of skin care, refreshing, emotion pacifying and anxiety relieving, and is deficient in antiviral and antibacterial aspects. The essential oil is prepared from 3-5 parts of sweet orange essential oil, 0.5-1 part of peppermint essential oil, 1-2 parts of tea tree essential oil, 1-2 parts of pine needle essential oil, 1-2 parts of lemon essential oil, 0.5-1 part of rosmarinus leaf essential oil, 0.5-1 part of pogostemon cablin essential oil, 1-2 parts of eucalyptus essential oil, 0.5-1.5 parts of lavender essential oil and 1-2 parts of geranium essential oil; and the CAS number of the sweet orange essential oil is 8028-48-6, the main component of the sweet orange essential oil is Dlimonene, and the CAS number of the peppermint essential oil is 8006-90-4. the main component of the peppermint essential oil is menthol, the CAS number of the tea tree essential oil is 68647-73-4, and the main component of the tea tree essential oil is terpinen-4 alcohol.

The invention discloses a traditional Chinese medicine protection pad of a female breast health bra. The traditional Chinese medicine protection pad is prepared from the following raw materials in parts by weight: 1 to 2 parts of dipotassium glycyrrhizinate, 8 to 15 parts of semen citri reticulatae, 8 to 15 parts of pericarpium citri reticulatae viride, 3 to 8 parts of rhizoma sparganii, 3 to 8 parts of rhizoma curcumae, 10 to 20 parts of radix bupleuri, 10 to 20 parts of rhizoma cyperi, 8 to 15 parts of lightyellow sophora root, 3 to 8 parts of semen brassicae, 3 to 8 parts of herba asari, 8to 15 parts of semen vaccariae, 3 to 8 parts of flos caryophylli, 8 to 15 parts of herba leonuri, 8 to 15 parts of radix curcumae, 3 to 8 parts of radix angelicae dahuricae, 3 to 8 parts of spina gleditsiae, 3 to 8 parts of olibanum, 3 to 8 parts of myrrh and 5 to 12 parts of borneol. According to the traditional Chinese medicine protection pad provided by the invention, volatile components of medicines are directly absorbed through breast skin tissues so that the medicines rapidly reach acting parts and directly permeate to be absorbed, so that the effects of dredging channels and collateralsand reaching inner parts to smoothen internal organ qi movement, dredging main and collateral channels, coordinating yin and yang, effectively alleviating female breast related diseases and even realizing the aim of healing diseases are realized.

The invention discloses a damping massage shoe which comprises a shoe body, damping devices and massage devices. The damping devices are arranged at the bottom of the shoe body, the massage devices are arranged on the tops of the damping devices, the shoe body comprises a shoe sole and a shoe upper, the shoe upper is arranged on the top of the shoe sole, an inner groove is formed in the shoe sole,a plurality of sets of damping devices are arranged at the bottom of the inner groove, and each damping device comprises a top plate, a bottom plate, rubber columns, an upper sealing plate, a lower sealing plate, a protective sleeve, a plurality of inner plates and a rubber layer, wherein the bottom of the top plate is provided with the upper sealing plate, and the lower sealing plate is arrangedbelow the upper sealing plate. The damping massage shoe has the advantages that the design is reasonable, the structure is simple, the wearing comfort of people is effectively improved, foot or bodyhealth of people is effectively protected, and the shoe safety and practicability are effectively improved.

The present invention provides methods for treating individuals having a hepatitis C virus (HCV) infection, which individuals have failed to respond to therapy with an IFN-α other than consensus interferon (CIFN), or who, following cessation of therapy with an IFN-α other than CIFN, have suffered relapse. The methods generally involve a treatment regimen comprising administering a first dosing regimen of CIFN, followed by a second dosing regimen of CIFN. Ribavirin is administered with at least the second dosing regimen.

The invention relates to a dietary fiber product for relieving chronic colitis and a preparation method thereof. The dietary fiber product is prepared from the following components in parts by weight:20-28 parts of corn meal, 27-38 parts of dietary fiber powder, 4-7 parts of vegetable fat powder, 9-16 parts of protein powder, 1-7 parts of vitamins and minerals and 1-2 parts of stabilizer. The dietary fiber product prepared in the invention is scientifically blended with other nutritional ingredients based on the dietary fiber powder, such as protein powder, vegetable fat powder, vitamins andminerals and the like; through synergistic effect of the nutritional ingredients, the body needs for nutritional ingredients are guaranteed comprehensively; the dietary fiber product is suitable for preventing or treating chronic colitis; through proper nutrition proportioning, the nutrition characteristics of high protein, low fat and high fiber are guaranteed, the intestinal flora of the patientare scientifically regulated, the inflammation is relieved, the chronic colitis is eased, the intestinal health is maintained, and the body immunity is improved.

The invention relates to a preparation method of a compound serving as a neuroprotective agent. By using the method, the original ten-step synthesis is simplified into six-step synthesis, so that the method is simpler and more feasible and is suitable for large-scale production.

The invention provides methods and compositions for identifying modulators, particularly peptide modulators, of cell surface receptor activity. Specifically, the invention provides a cell containing a recombinant nucleic acid encoding a polypeptide modified for intracellular presentation, which cell may further comprise one or both of a recombinant nucleic acid encoding a binding partner for that polypeptide and recombinant nucleic acid encoding a test polypeptide. The subject cell may be a member of a library of cells, and the library may be used in screening methods for identifying test polypeptides (e.g., conformationally restrained polypeptides) having cell surface receptor modulatory activity. The invention finds use in a variety of drug-discovery applications.

The invention discloses an application of rapamycin in preparation of a drug for treating diseases caused by Msi1 gene ectopic overexpression. According to the invention, the inhibitor rapamycin of the m-TOR pathway is used for treating the skin abnormal Paget-like disease caused by Msi1 gene ectopic overexpression for the first time. A rapamycin drug is applied to a mouse model, so that the phenotype of the disease can be well relieved, and the effect of relieving the disease is achieved. Besides, the researched and developed drug is applied to EMPD patients, and a relatively good clinical effect is achieved. The invention provides the new drug for treating the extramammary Paget disease of mice and people.